Anzeige
Mehr »
Login
Mittwoch, 26.02.2025 Börsentäglich über 12.000 News von 688 internationalen Medien
Die DeepSeek-Revolution: Pioneer AIs Multi-Agent-Strategie lässt die Konkurrenz alt aussehen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 866251 | ISIN: US09061H3075 | Ticker-Symbol:
NASDAQ
26.02.25
21:22 Uhr
0,736 US-Dollar
+0,076
+11,51 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOMERICA INC Chart 1 Jahr
5-Tage-Chart
BIOMERICA INC 5-Tage-Chart

Aktuelle News zur BIOMERICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14:42Biomerica gains EU certification for IBD food intolerance products1
14:34Biomerica erhält EU-Zertifizierung für Nahrungsmittelunverträglichkeitsprodukte bei CED1
14:24Biomerica, Inc.: Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis47Significant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union standards and allowing sales of the products in the...
► Artikel lesen
19.02.Biomerica, Inc.: Biomerica's inFoods IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal99inFoods IBS Provides Personalized Diet Therapy for Patients Suffering with Irritable Bowel Syndrome (IBS)Research Finds Patients Following a Personalized Diet Therapy Created with inFoods® IBS, Experienced...
► Artikel lesen
BIOMERICA Aktie jetzt für 0€ handeln
16.01.Biomerica Stock Trades 200% Higher After Prostate Screening Test Receives Approval10
16.01.Biomerica's rapid PSA test gains UAE approval7
16.01.Biomerica, Inc.: United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel PSA Screening Test to Detect an Early Sign of Prostate Cancer2
15.01.Biomerica Posts $1.64 Mln In Q2 Revenue, Marks 5% Year-over-Year Growth1
15.01.Biomerica reports Q2 results3
15.01.Biomerica, Inc.: Biomerica Reports Second Quarter Fiscal 2025 Financial Results222- Total Revenue Increases 5% Year-Over-Year - Achieves Sustained Revenue Growth, Improved Gross Margins, and Significant Cost Savings IRVINE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE)...
► Artikel lesen
14.01.BIOMERICA INC - 10-Q, Quarterly Report-
20.12.24BIOMERICA INC - S-8, Securities to be offered to employees in employee benefit plans-
17.12.24BIOMERICA INC - 8-K, Current Report-
25.11.24BIOMERICA INC - S-8, Securities to be offered to employees in employee benefit plans-
21.11.24Biomerica secures patents for GI treatments in Europe1
21.11.24Biomerica, Inc.: Biomerica Secures Three Key International Patents for inFoods Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis1
07.11.24Biomerica, Inc.: Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements141IRVINE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a leading global provider of advanced medical diagnostics, announced that it has been granted an additional 180-day...
► Artikel lesen
07.11.24Biomerica erhält Fristverlängerung zur Wiedererlangung der Nasdaq-Konformität2
07.11.24Biomerica granted extension to regain Nasdaq compliance1
06.11.24BIOMERICA INC - 8-K, Current Report-
Seite:  Weiter >>
29 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1